- Home
- KALA vs STEC Comparison
KALA vs STEC Comparison
Compare KALA & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- STEC
- Stock Information
- Founded
- KALA 2009
- STEC 2006
- Country
- KALA United States
- STEC Hong Kong
- Employees
- KALA N/A
- STEC N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- KALA Health Care
- STEC
- Exchange
- KALA Nasdaq
- STEC NYSE
- Market Cap
- KALA 26.2M
- STEC 63.8M
- IPO Year
- KALA 2017
- STEC 2021
- Fundamental
- Price
- KALA $7.14
- STEC $0.74
- Analyst Decision
- KALA Strong Buy
- STEC
- Analyst Count
- KALA 3
- STEC 0
- Target Price
- KALA $14.00
- STEC N/A
- AVG Volume (30 Days)
- KALA 198.2K
- STEC 10.9K
- Earning Date
- KALA 08-05-2025
- STEC 08-05-2025
- Dividend Yield
- KALA N/A
- STEC N/A
- EPS Growth
- KALA N/A
- STEC N/A
- EPS
- KALA N/A
- STEC N/A
- Revenue
- KALA N/A
- STEC $10,672,000.00
- Revenue This Year
- KALA N/A
- STEC $9,392.20
- Revenue Next Year
- KALA N/A
- STEC N/A
- P/E Ratio
- KALA N/A
- STEC N/A
- Revenue Growth
- KALA N/A
- STEC N/A
- 52 Week Low
- KALA $2.92
- STEC $0.20
- 52 Week High
- KALA $11.20
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- KALA 59.52
- STEC 40.44
- Support Level
- KALA $5.35
- STEC $0.70
- Resistance Level
- KALA $8.49
- STEC $0.80
- Average True Range (ATR)
- KALA 0.81
- STEC 0.08
- MACD
- KALA 0.17
- STEC 0.00
- Stochastic Oscillator
- KALA 57.01
- STEC 38.55
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.